MOG (35 - 55) mouse rat (12668-05)
Sequence (1LC):
Sequence (3LC):
H - Met - Glu - Val - Gly - Trp - Tyr - Arg - Ser - Pro - Phe - Ser - Arg - Val - Val - His - Leu - Tyr - Arg - Asn - Gly - Lys - OH
Catalog :
5 mg
$600  (For other quantities please Contact Us or call 972-420-8505 (USA) 800-227-0627 (INTL.) or Fax 972.420.0442)
Each vial contains lyophilized solid packaged under an inert gas and supplied as a trifluoroacetate salt
Myelin oligodendrocyte glycoprotein (MOG) 35-55, a minor component of CNS myelin,  is expressed in central nervous system myelin which produces a relapsing-remitting neurological diesease with extensive plague-like demyelination. It is believed to be a target autoantigen in multiple sclerosis. MOG 35-55 peptide is an immunodominant epitope of MOG that induces strong T and B cell responses and Induces experimental autoimmune encephalomyelitis in rodents. A single injection of this peptide produces a relapsing-remitting neurologic disease with extensive plaque-like demyelination. This Cysteine containing MOG (35-55) peptide can be use to induced polyclonal anti-MOG(35-55) antibody production in rabbits with high specificity, high affinity, and high titer indicating its high purity, as well as suitability for peptide-coated ELISA and Western blot assay. Immunization with MOG (35-55) suppresses spontaneous regeneration of dopaminergic neurons injured with MPTP.

Product Usage:
This product is for research use only. Not for use in diagnostic or therapeutic procedures.
  1. Encinas, J. et al. Nature Genetics 21, 158 (1999)
  2. Hisahara, S. EMBO J. 19, 341 (2000)
  3. Ford, M. and BJ. Evavold, Immunol. 171, 1247 (2003)
  4. Kort, J. et al. J. Neuroimmunol. [Epub ahead of print] Dec 28, (2005).